Tahereh Foroutan1, Aisan Farhadi2, Saeed Abroun3, Bahram Mohammad Soltani4. 1. Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran. Electronic address: foroutan@khu.ac.ir. 2. Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran. 3. Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. 4. Department of Genetic, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
Umbilical cord blood is used for transplantation in
regenerative medicine for hematological disorders.
Improvement of hematopoietic reconstitution and
engraftment potential of ex vivo-expanded hematopoietic
stem cells has been unsuccessful due to the inability to
generate an adequate amount of stem cells. Many studies
report that control of in vitro hematopoietic stem cell
(HSC) self-renewal is difficult. Hematopoietic cytokines
fail to support reliable amplification of in vitro HSCs
and additional factors appear to be needed (1). Recently,
factors such as feeder layers are suggested to affect
HSCs expansion (2). Expanded HSCs derived from cord
blood cultured on a feeder layer of mesenchymal stem
cells (MSCs) have reduced apoptosis rates (3). Adiposederived
stem cells (ADSCs) show properties similar to
that observed in bone marrow MSCs. Because of the ease
of accessibility human, researchers consider ADSCs to be
an attractive source for regenerative medicine (4). ADSCs
are immunoprivileged, prevent severe graft-versus-host
disease, and stable in culture (5). ADSCs show high
intrinsic expression of self-renewal factors compared to
bone marrow-derived MSCs (2). In the current study, we
have used ADSCs as a feeder layer for HSC expansion
because they produce various factors to support stem cell
maintenance and cell growth.MicroRNAs, a large group of negative gene regulators,
work through a post-transcriptional suppression
mechanism. MicroRNAs play an important role in
proliferation, differentiation, and apoptosis (6). They
are short, noncoding RNAs, usually 18-25 nucleotides
in length, which repress translation and cleave mRNA
by base pairing to the 3′untranslated region of the target
genes (7). Although various numbers of microRNAs have
been studied in HSCs, there are few reports that pertain
to the function of miR-145. HumanmiR-145 is broadly
expressed in germline and mesoderm-derived tissues such
as the breast (8), ovaries (9), testes, uterus, prostate, heart,
and spleen (6). Sachdeva and Mo (6) have reported miR-145 mediated suppression of cell growth, invasion, and
metastasis. Based on these findings, they proposed that as a tumor suppressor, miR-145 might be a valuable biomarker
for cancer diagnosis. Starczynowski et al. (7) reported
that deletion of chromosome 5q in patients with 5-q32-33
syndrome correlated with the loss of miR-145 and miR-146a,
two microRNAs frequently observed in HSCs. It was reported
that in various cancers, miR-145 prevents tumor angiogenesis
and metastasis by targeting c-Myc (10, 11). In the present
research, we have investigated the expression levels of p53 and
miR-145 in HSCs after culture on feeder layers of ASDCs. It
is well known that p53 upregulates miR-145 expression (12).
Previous studies have shown the transcriptional induction
of miR-145 by p53 in response to anticancer drugs or serum
starvation. p53 induces expression of tumor suppressor miR-
145 (13, 14). In this study, we investigated the expression
levels of p53 and miR-145 in HSCs after culture on a feeder
layer of ADSCs.
Materials and Methods
Adipose-derived stem cell culture
We obtained human subcutaneous adipose tissue samples
from donors who underwent abdominoplasty in Erfan
Hospital Iran). The patient gave consent to use of donated
samples in the present study. The tissue samples were
processed according to a modified procedure by Zuk et al.
(15), which included 0.075% collagenase II (Sigma-Aldrich,
St. Louis, MO) for 30 minutes, followed by centrifugation
at 150 g for 5 minutes. The pellet was washed three times
in phosphate buffered saline (PBS, Gibco, Germany), then
we seeded the cells at 105 cells/dish and cultured them
in Dulbecco’s modified eagle’s medium (DMEM, Gibco,
Germany), 10% fetal bovine serum (FBS, Gibco, Germany),
and 100 U/ml penicillin/streptomycin. Human HSCs were
obtained from Royan Institute. The Institutional Review
Board and Ethical Committee of Royan approved the HSCs
extraction method.
Proliferation and phenotype analyses
We used flow cytometry to detect ADSCs surface
markers monoclonal antibodies were used for CD73,
CD90, and CD105 markers. To enable differentiation into
osteoblast cells, we used passage-4 ADSCs and a medium
that consisted of high glucoseDMEM, 10% FBS, 10 nM
dexamethasone (Sigma-Aldrich, USA), 35 mg/mL of
ascorbic acid, and 1 mM β-glycerophosphate (Chemicon,
USA). Cells were incubated in 5% CO2 at 37˚C for 21
days. We used alizarin red to confirm differentiation into
osteoblast cells. An alkaline phosphatase kit (Sigma-
Aldrich) was used for alkaline phosphatase activity.
CD34+ cell isolation and culture (group design)
Mononuclear cells were separated with Ficoll (1.077 ±
0.001 kg/L, Sigma-Aldrich, USA). Next, we incubated
these cells with anti-CD34 antibody labeled with Fe
nanoparticles (America Milton Biotech), after which
CD34+ cells were separated by manual cell separation
using a MACS column (America Milton Biotech). Anti-
CD34 were used to confirm the CD34 marker in isolated
cells obtained from umbilical cord blood. After feeder layer
preparation with mitomycin C the CD34+ cells were cultured
under the following 4 culture conditions for 7 days: i. Stem
span medium only supplemented with 100 ng/ml of the
following cytokines: stem cell factor (SCF), thrombopoietin
(TPO), and fetal liver tyrosine kinase 3 ligand (Flt-3L), ii.
Direct culture on an ADSCs feeder layer, iii. Indirect culture
on an ADSCs feeder layer (ThinCert™ plate with a 0.4 μm
pore size), and iv. Control group of cells analyzed immediately
after extraction.
MTT assay
The 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide (MTT) assay was used to assess cell viability for
all groups. This assay measures the amount or ratio of cell
proliferation. It is a colorimetric assaydependent on the
reduction of the tetrazolium salt, MTT, to form blue formazan
crystals. After incubation, we removed the overlying culture
medium and added MTT. Next, the cells were incubated for
4 hours in an incubator in CO2 at 37˚C. Isopropanol acid was
added and we read the optical density (OD) of the obtained
solution at 630nm as the reference wavelength and 570 nm as
the measurement wavelength using the ELISA reader. Oneway
ANOVA was used for data analysis.
Annexin V evaluation of apoptotic cells
We used an Apoptosis kit (Bioscience, USA) for
apoptosis analysis. At culture day 14, we treated 1×104
cells resuspended in 1x binding buffer with fluorochromeconjugated
annexin V for 10 minutes. Next, cells were
washed and resuspended in 1x binding buffer. A propidium
iodide (PI) solution was added and fluorescence of the
stained cells was analyzed by flow cytometry.
Reverse transcription and real-time polymerase chain
reaction
RNA was extracted from sample cells using TRIzol
(Fermentas, Germany). The cDNA was synthesized using
a cDNA synthesis kit (Fermentas, Germany) based on the
manufacturer’s instructions.Primers were designed according
to the NCBI website and synthesized by Bioneer Company.
SYBER green master mix was used for the polymerase chain
reaction (PCR) reactions (Applied Biosystems, USA). The
real time quantitative (qRT) PCR program was performed
with a melting cycle for 5 minutes at 95˚C followed by
10 seconds at 95˚C, 40 cycles of melting, 15 seconds at
60˚C (annealing), and 30 seconds at 72˚C (extension). The
sequences for GAPDH, p53, and MiR-145 are as follows:F: 5′-TCCTCAGCATCTTATCCGAGTG-3́R: 5́-AGGACAGGCACAAACACGCACC-3 ´F: 5′-ATGGGGAAGGTGAAGGTCG-3 ´R: 5 ´-GGGGTCATTGATGGCAACAATA-3 ´F: 5′-GTCCAGTTTCCCABGGAA-3′R: 5́-TGACCCCAGGTAACTCTGAGTGT-3 ´
Statistical analysis
Data are presented as mean standard deviation (SD).
We used the two-way ANOVA and Duncan test for
data analysis. Differences were considered significant
at P<0.05. In the present study, all experiments were
repeated 3 times.
Results
We performed flow cytometry analyses of the ADSC
surface antigen markers, which resulted inpositive
reactions for CD105 (98.4%), CD90 (80.5%), and CD73
(87.3%) antibodies. ADSCs were negative for CD45
(0.302%) (Fig .1). Cultured hematopoietic stem cells on
an adipose-derived stem cell feeder layer after 2 and 7
days have shown in Figure 2. We performed alizarin red
staining to assess the ability of ADSCs to differentiate
osteoblast cells. The results confirmed the osteogenic
potential of the ADSCs (Fig .3).
Fig.1
Flow cytometry analysis of adipose-derived stem cell (ADSCs), markers showed positive expressions of 98.4% of ADSCs, CD105+, 87.3% cells are
CD73+, 80.5% are CD90 and 0.303% are CD45 positive.
Fig.2
Cultured hematopoietic stem cells on an adipose-derived stem cell feeder layer. A. After 2 days and B. After 7 days.
Fig.3
Osteogenic differentiation of adipose-derived stem cell, 200. A. Positive reaction in osteoblastic differentiated cells with alizarin red staining, B.
Undifferentiated cells, C. Osteoblast differentiated cells with increased alkaline phosphatase activity, and D. Undifferentiated cells.
We found that p53 expressed less than the other groups.
Our results showed lower expression of the p53 gene on
the ThinCert™ plate with 0.4 μm pore size compared to
HSCs cultured directly on the ADSCs feeder layer. The
microporous membrane prevented direct contact between
HSCs and the feeder layer. Consequently, there was
increased p53 expression compared to cells that had direct
contact with the ADSC feeder layer (Fig .4).
Fig.4
Analysis of p53 and miR-145 expressions by reverse transcription
PCR in A, B, C, and D groups. A; Fresh CD34+ cells, B; CD34+ cells cultured
in the presence of cytokines, C; CD34+ cells indirectly cultured on feeder
layer, and D; CD34+ cells directly cultured on feeder layer. GAPDH group
was considered the control group.
Results of (qRT) PCR analysis were the same as RTPCR
analysis. We observed the highest expression of
the p53gene in CD34+HSCs (P<0.05). There was lower
p53expression in the presence of the ADSC feeder layer
compared to the other experiments (P<0.05, Fig .5).
Analysis of miR-145 expression in fresh CD34+ cells
by real-time polymerase chain reaction compared to the
other groups has shown in Figure 6.
Fig.5
Analysis of p53 gene expression in fresh CD34+ cells by real-time
polymerase chain reaction compared to the other groups.
A; p53 gene expression in fresh CD34+ cells, B; Expression of p53 in
CD34+ cells in the presence of cytokines, C; Expression of p53 in CD34+ cells
indirectly cultured on the feeder layer, D; Expression of p53 in CD34+ cells
directly cultured on the feeder layer. Fresh CD34+ cells showed significant
increase in p53 gene expression compared to the other groups, and *;
P<0.05.
Flow cytometry analysis of adipose-derived stem cell (ADSCs), markers showed positive expressions of 98.4% of ADSCs, CD105+, 87.3% cells are
CD73+, 80.5% are CD90 and 0.303% are CD45 positive.Cultured hematopoietic stem cells on an adipose-derived stem cell feeder layer. A. After 2 days and B. After 7 days.Osteogenic differentiation of adipose-derived stem cell, 200. A. Positive reaction in osteoblastic differentiated cells with alizarin red staining, B.
Undifferentiated cells, C. Osteoblast differentiated cells with increased alkaline phosphatase activity, and D. Undifferentiated cells.Analysis of p53 and miR-145 expressions by reverse transcription
PCR in A, B, C, and D groups. A; Fresh CD34+ cells, B; CD34+ cells cultured
in the presence of cytokines, C; CD34+ cells indirectly cultured on feeder
layer, and D; CD34+ cells directly cultured on feeder layer. GAPDH group
was considered the control group.Analysis of p53 gene expression in fresh CD34+ cells by real-time
polymerase chain reaction compared to the other groups.A; p53 gene expression in fresh CD34+ cells, B; Expression of p53 in
CD34+ cells in the presence of cytokines, C; Expression of p53 in CD34+ cells
indirectly cultured on the feeder layer, D; Expression of p53 in CD34+ cells
directly cultured on the feeder layer. Fresh CD34+ cells showed significant
increase in p53 gene expression compared to the other groups, and *;
P<0.05.Analysis of miR-145 expression in fresh CD34+ cells by real-time
polymerase chain reaction compared to the other groups.A; miR-145 expression in fresh CD34+ cells, B; Expression of miR-145 in
CD34+ cells in the presence of cytokines, C; Expression of miR-145in CD34+
cells indirectly cultured on the feeder layer, D; Expression of miR-145 in
CD34+ cells directly cultured on the feeder layer. Fresh CD34+ cells showed
significant increase in miR-145 expression compared to the other groups,
and *; P<0.05.
Discussion
Our results have shown that HSCs had higher selfrenewal
in the presence of the ADSCs feeder layer
compared to the other groups. Because of insufficient
numbers of HSCs, expansion of these cells is important
for clinical applications. Recently, it was reported that
a bone marrow MSC feeder layer along with cytokines
such as SCF and TPO increased proliferation of HSCs
(2). Glettig and Kaplan (16) reported that different feeder
layers for HSCs limited the differentiation of these cells.
Our data revealed that the expression of p53 as a selfrenewal
inhibitor gene in HSCs cultured on a feeder
layer was lower than the other groups. Tumor suppressor
p53 has been shown to direct regulation of a number of
microRNAs such as the miR-34 family and miR-145 (17).
Sachdeva et al. (13) reported suppression of c-Myc by
p53-induced miR-145. miR-145 was reported to inhibit
various cancers by targeting several protein coding genes
such as c-Myc. p53 represses c-Myc through induction
of the tumor suppressor miR-145 (14). Suzuki et al. (18)
reported that a central tumor suppressor, p53, enhanced
the post-transcriptional maturation of several microRNAs
with growth-suppressive function, including miR-143
and miR-145, and miR-16-1.Suh et al. (19) have found that miR-145 is regulated by
DNA methylation and p53 gene mutation in some cancers,
and p53 increased the expression level of miR-145. Dong et
al. (17) established a new link between p53 and miR-145 in
tumor growth regulation and metastasis in ovarian carcinoma.
There have been no comprehensive studies on the role of
microRNAs in HSCs. Our findings showed lower expression
levels of p53 and miR-145 in HSCs cultured on ADSCs
compared to the groups without feeder layers. In terms of
the tumor suppressive role of miR-145 and p53, reduced
expression of these two genes in the present study indicated
that ASDCs could cause growth induction by inhibition of
apoptosis. Downregulation of p53 and consequently miR-145
in HSCs could cause increased proliferation of HSC. On the
other hand it has been shown that miR-145 is induced during
differentiation, and it directly silences stem cell self-renewal
and pluripotency (20). The results of the present study
suggested that suppression of miR-145 of HSCs cultured on
ASCs altered the p53-mediated cell cycle arrest.Our results showed that the expression of miR-145 and
p53 gene on a Thin Cert™ plate with 0.4 μm pore sized
groups were lower than HSCs cultured directly on the
ASCs feeder layer group. It has been shown that direct
contact between HSCs and a feeder layer was critical for
expansion of cells (2). da Silva et al. (21) reported that
direct contact of HSCs and a feeder layer could increase
HSC self-renewal. Alakel et al. (22) showed that direct
contact between HSCs and a bone marrow MSCs feeder
layer could improve self-renewal of HSCs and can affect
migratory behavior of HSCs.
Conclusion
miR-145 appears to increase proliferation of HSC
cultured on ADSCs by impairing p53 function. Defining
the role of ADSCs in controlling the HSC self-renewal
through reduced miR-145 and p53 may lead to the
treatment and prevention of hematopoietic disorders.
Improvement of HSCs self-renewal direct cultured on
ADSCs is associated with reduced expression of miR-145
and p53.
Authors: Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick Journal: Mol Biol Cell Date: 2002-12 Impact factor: 4.138
Authors: Seong O Suh; Yi Chen; Mohd Saif Zaman; Hiroshi Hirata; Soichiro Yamamura; Varahram Shahryari; Jan Liu; Z Laura Tabatabai; Sanjay Kakar; Guoren Deng; Yuichiro Tanaka; Rajvir Dahiya Journal: Carcinogenesis Date: 2011-02-23 Impact factor: 4.944
Authors: Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore Journal: J Clin Invest Date: 2011-06-06 Impact factor: 14.808
Authors: Daniel T Starczynowski; Florian Kuchenbauer; Bob Argiropoulos; Sandy Sung; Ryan Morin; Andrew Muranyi; Martin Hirst; Donna Hogge; Marco Marra; Richard A Wells; Rena Buckstein; Wan Lam; R Keith Humphries; Aly Karsan Journal: Nat Med Date: 2009-11-08 Impact factor: 53.440